1Nakamura TM, Morin GB, Chapman KB, et al. Telomerase catalytic subunit homologs from fission yeast and human. Science, 1997, 277: 955-959.
2Meyerson M, Christopher MC, Eaton EN, et al. HEST2, the putative human telomerase catalytic subunit gene is up-regulated in tumor cells and during immortalization. Cell, 1997,90:785-795.
3Seol JG, Kim KS, Park WH, et al. Telomerase activity in acute myelogenous leukemia: clinical and biological implications. Br J Haematol,1998,100: 156-165.
4Ohyashiki JH, Ohyashiki K, Iwana H, et al. Clinical implications of telomerase activity levels in acute leukemia. Clin Cancer Res, 1997, 3:619.
5Takakura M, Kyo S, Kanaya T, et al. Expression of human telomerase subunits and correlation with telomerase activity in cervical cancer. Cancer Res, 1998,58:1558-1561.
6Klingelhuta AJ. Telomerase activation and cancer. J Mol Med, 1997,75:45.
7Dome JS, Look AT. Three molecular determinants of malignant conversion and their potential as therapeutic targets. Curr Opin Oncol, 1999,11 : 58-67.
8Yokayama Y, Takahashi Y, Shinohara A, et al. The 5 -End of hTERT mRNA is a good garget for hammerhead ribozyme to suppress telometase activity. Biochem Biophys Res Comm, 2000,273:316-321.
